Zhu X - Search Results

1

Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma.

Liu R, Cui H, Li D, Guo X, Zhang Z, Tan S, Zhu X. Liu R, et al. Among authors: zhu x. J Hepatocell Carcinoma. 2024 Dec 19;11:2493-2504. doi: 10.2147/JHC.S500084. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39717509 Free PMC article. Review.

2

Downregulated CMTM2 Poses Potential Clinical Significance in Hepatocellular Carcinoma.

Guo X, Zhang S, Tan S, Bei C, Zhang H, Zhu X, Qiu X. Guo X, et al. Among authors: zhu x. DNA Cell Biol. 2020 Apr;39(4):683-689. doi: 10.1089/dna.2019.5237. Epub 2020 Jan 28. DNA Cell Biol. 2020. PMID: 31990600

3

Clinical Significance of TUBGCP4 Expression in Hepatocellular Carcinoma.

Zheng C, Zhang J, Jiang F, Li D, Huang C, Guo X, Zhu X, Tan S. Zheng C, et al. Among authors: zhu x. Anal Cell Pathol (Amst). 2022 Dec 8;2022:9307468. doi: 10.1155/2022/9307468. eCollection 2022. Anal Cell Pathol (Amst). 2022. PMID: 36530949 Free PMC article.

4

Prognostic value of CMTM6 protein in hepatocellular carcinoma involving the regulation of the immune microenvironment.

Wei Z, Guo X, Li D, Wang J, Lin C, Tan C, Wang Y, Zhu X, Tan S. Wei Z, et al. Among authors: zhu x. Int J Biol Macromol. 2024 Aug;275(Pt 2):133618. doi: 10.1016/j.ijbiomac.2024.133618. Epub 2024 Jul 5. Int J Biol Macromol. 2024. PMID: 38971275

5

Clinical significance of CMTM4 expression in hepatocellular carcinoma.

Bei C, Zhang Y, Wei R, Zhu X, Wang Z, Zeng W, Chen Q, Tan S. Bei C, et al. Among authors: zhu x. Onco Targets Ther. 2017 Nov 14;10:5439-5443. doi: 10.2147/OTT.S149786. eCollection 2017. Onco Targets Ther. 2017. PMID: 29180877 Free PMC article.

6

Correlations between chromobox homolog 8 and key factors of epithelial-mesenchymal transition in hepatocellular carcinoma.

Zhu X, Luo W, Bei C, Kong J, Zhang S, Fu Y, Li D, Tan S. Zhu X, et al. Cancer Cell Int. 2019 Dec 17;19:340. doi: 10.1186/s12935-019-1063-z. eCollection 2019. Cancer Cell Int. 2019. Retraction in: Cancer Cell Int. 2020 Oct 7;20:486. doi: 10.1186/s12935-020-01574-4 PMID: 31889893 Free PMC article. Retracted.

7

Okadaic acid promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting protein phosphatase 2A.

Kong J, Li D, Zhang S, Zhang H, Fu Y, Qian B, Bei C, Tan S, Zhu X. Kong J, et al. Among authors: zhu x. J Cell Biochem. 2020 Jan 6. doi: 10.1002/jcb.29629. Online ahead of print. J Cell Biochem. 2020. Retraction in: J Cell Biochem. 2024 Jul;125(7):e30607. doi: 10.1002/jcb.30607 PMID: 31904141 Retracted.

8

Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.

Zhang S, Tian R, Bei C, Zhang H, Kong J, Zheng C, Song X, Li D, Tan H, Zhu X, Tan S. Zhang S, et al. Among authors: zhu x. Onco Targets Ther. 2020 Jun 17;13:5731-5741. doi: 10.2147/OTT.S250370. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606785 Free PMC article.

9

Expression and clinical significance of CMTM1 in hepatocellular carcinoma.

Song X, Zhang S, Tian R, Zheng C, Xu Y, Wang T, Bei C, Zhang H, He X, Zhu X, Tan S. Song X, et al. Among authors: zhu x. Open Med (Wars). 2021 Jan 28;16(1):217-223. doi: 10.1515/med-2021-0221. eCollection 2021. Open Med (Wars). 2021. PMID: 33585698 Free PMC article.

10

Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma.

Tan S, Guo X, Bei C, Zhang H, Li D, Zhu X, Tan H. Tan S, et al. Among authors: zhu x. BMC Cancer. 2022 Aug 19;22(1):905. doi: 10.1186/s12885-022-09999-y. BMC Cancer. 2022. PMID: 35986302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,068 results

Search Page

Filters